Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -998 | -4,029 | -3,037 | -2,055 | -940 |
| Depreciation Amortization | 92 | 124 | 79 | 60 | 35 |
| Accounts receivable | -1 | 16 | -14 | -6 | -7 |
| Accounts payable and accrued liabilities | 78 | 112 | 294 | 199 | 70 |
| Other Working Capital | 48 | 400 | 311 | 210 | 66 |
| Other Operating Activity | 432 | 2,239 | 1,455 | 924 | 406 |
| Operating Cash Flow | $-348 | $-1,138 | $-912 | $-667 | $-372 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -9 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-9 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 425 | 1,616 | 1,258 | 832 | 461 |
| Debt Repayment | -75 | -500 | -378 | -191 | -102 |
| Financing Cash Flow | $350 | $1,116 | $881 | $642 | $359 |
| Beginning Cash Position | N/A | 31 | 31 | 31 | 31 |
| End Cash Position | 2 | N/A | N/A | 6 | 18 |
| Net Cash Flow | $2 | $-31 | $-31 | $-26 | $-13 |
| Free Cash Flow | |||||
| Operating Cash Flow | -348 | -1,138 | -912 | -667 | -372 |
| Capital Expenditure | N/A | -9 | N/A | N/A | N/A |
| Free Cash Flow | -348 | -1,147 | -912 | -667 | -372 |